Close
  • SMC open account icon Open an A/C
    • Open an A/C
    • CHOOSE YOUR OPTION(S)
    • Trading A/c
    • Mutual Fund A/c
    • NBFC A/c
    • NPS A/c
  • SENSEX Apr 29 2024 02:49
    74,567.65 +837.49 ( +1.14%)
  • NIFTY Apr 29 2024 02:44
    22,608.30 +188.35 ( +0.84%)
  • SENSEX Apr 29 2024 02:49
    74,567.65 +837.49 ( +1.14%)
  • NIFTY Apr 29 2024 02:44
    22,608.30 +188.35 ( +0.84%)
  • Nasdaq Apr 27 2024 04:30
    15,927.90 +316.14 ( +2.03%)
  • DJIA Apr 27 2024 04:30
    38,239.66 +153.86 ( +0.40%)
  • S&P 500 Apr 27 2024 04:30
    5,099.96 +51.54 ( +1.02%)
  • Hang Seng Apr 29 2024 02:10
    17,746.91 +95.76 ( +0.54%)
  • Crude Oil Apr 29 2024 02:39
    6,976.00 -23.00 (-0.33%)
  • Gold Apr 29 2024 02:50
    71,545.00 +45.00 ( +0.06%)
  • Silver Apr 29 2024 02:39
    80,860.00 +180.00 ( +0.22%)
  • Copper Apr 29 2024 02:25
    858.00 +2.20 ( +0.26%)
  • Pound / Rupee Dec 23 2016 22:30
    104.10 +0.39 ( +0.38%)
  • Dollar / Rupee Dec 23 2016 22:30
    83.32 +0.01 ( +0.01%)
  • Euro / Rupee Dec 23 2016 22:30
    89.30 +0.19 ( +0.22%)
  • Yen / Rupee Dec 23 2016 22:30
    0.54 0.00 (-0.34%)

BSE Code : | NSE Symbol : | ISIN:| SECTOR : |

NSE BSE
 

Volume

Prev. Close

Open Price

Bid Price (QTY)

Offer Price (QTY)

 

Today’s High/Low -

52 wk High/Low -

Key Stats

MARKET CAP (RS CR) 4068.41
P/E 5.71
BOOK VALUE (RS) 500.364459
DIV (%) 0
MARKET LOT 0
EPS (TTM) 44.8
PRICE/BOOK 0.510927575693381
DIV YIELD.(%) 0
FACE VALUE (RS) 5
DELIVERABLES (%)
4

News & Announcements

27-Oct-2023

Nirma standalone net profit declines 68.17% in the September 2023 quarter

21-Sep-2023

Glenmark Pharma divests 75% stake in Glenmark Life Sciences to Nirma

09-Aug-2023

Nirma standalone net profit declines 9.52% in the June 2023 quarter

26-May-2023

Nirma standalone net profit declines 21.76% in the March 2023 quarter

21-May-2011

Nirma to consider dividend

17-Aug-2010

Nirma's equity shareholders approves scheme of

23-Jul-2010

Nirma's equity shareholders to approve scheme of

01-Jun-2010

Nirma recommends dividend

Corporate Actions

Bonus
Splits
Dividends
Rights
Capital Structure
Book Closure
Board Meeting
AGM
EGM
 

Financials

Income Statement

Standalone
Consolidated
 

Peers Comparsion

Select Company Name BSE Code NSE Symbol
Arochem Silvassa Ltd 531593
Henkel SPIC India Ltd(merged) 500397 SPICFINE
Hipolin Ltd 530853
Kripa Chemicals Ltd 40264
Micron Chemicals Ltd 531614
Nilnita Chemicals Ltd (Merged) 512373
Pee Cee Cosma Sope Ltd 524136
Regaul Blue (India) Ltd 530661
Standard Surfactants Ltd 526231
Vashisti Detergents Ltd(merged) 523634 TATAVASHIS

Share Holding

Category No. of shares Percentage
Total Foreign 526320 0.33
Total Institutions 845 0.00
Total Govt Holding 0 0.00
Total Non Promoter Corporate Holding 106699 0.07
Total Promoters 144533701 90.82
Total Public & others 13974717 8.78
Total 159142282 100
  • Total Foreign
  • Total Institutions
  • Total Govt Holding
  • Total Non Promoter Corporate Holding
  • Total Promoters
  • Total Public & others

About Nirma Ltd

Nirma Limited (Nirma) was incorporated as a private limited company on 25th February 1980 to undertake the business of manufacturing and selling Synthetic Detergents, Soaps, Chemicals and Allied Products. It was promoted by Karsanbhai Patel as his pet project. The Company is engaged in the consumer goods and industrial products sector, having major manufacturing plants for production of various products includes Soda Ash, Linear Alkyl Benzene, Soaps, Detergents, Edible Salt, Industrial Salt and Others (Alfa Olefin Sulfonate, Sulfuric Acid, Glycerin and Single Super Phosphate). Also having separate unit for packaging. Nirma markets its products through its wholly owned subsidiary, Nirma Consumer Care Limited. The Company went to public in the year of 1993 as overcome from the status of deemed public limited. The Company came out with its maiden public issue of Equity Shares in the year 1994. During the same year, Nirma also ventured into manufacture of Fatty Acid, Glycerine, Toilet Soaps, Sulphuric Acid and Alfa Olefin Sulphonate (AOS). In 1995, the company had entered into an Agreement with Humphrey & Glasgow Consultants Ltd. for Detailed Engineering, construction supervision including Civil and Architectural Designs and Procurement Services for the Soda Ash Plant. During the year 1996, on account of modernisation, the company had successfully manufactured IP Grade (Pharmaceutical Grade) Glycerin. The associated companies including Nirma Detergents, Shiva Soaps and Detergents, Nirma Soaps and Detergents and Nilnita Chemicals were merged with the company during the period of 1996-1997. Nirma Consumer Care was formulated as a wholly-owned subsidiary of the company by the company in the year of 1997 itself. Nirma had completed successfully the state-of-the-art 80,000 TPA Linear Alkyl Benzene plant in the year 1998. During the year 1999, the edible salt market was set by the company to witness a keen battle with a new entrant, Nirma Salt, about to hit the market. In January of the year 2000, the 65,000 MTPA Normal Paraffin project was commissioned in a record 18 months time. Nirma had decided to acquire the business of Kisan Industries for the cash consideration of Rs 200 crore with effect from 1st April of the year 2000. During the year 2002, the company had undertaken the manufacturing process of toilet soap under the brand name 'Camay' for its subsidiary Nirma Consumer Care Ltd which obtains license from Procter & Gamble Home Products Ltd. In the same year of 2002, the company had closed its Bangladesh unit due to low sales volumes and entered into foods category with launch of Nirma Shudh Salt. Gujarat High Court approved the scheme of arrangement for demerger of operating division of Nirma Industries Ltd with the company in the year 2003. A tripartite agreement was made with Core Health Care Limited (CHL) and Assets Reconstruction Company (India) Limited in the matter of acquiring undertaking of CHL in the year of 2004. DURING 2004-05, the company had discontinued the production process at Pithampur in Madhya Pradesh and Jaipur in Uttar Pradesh. Nirma had obtained possession of some of the assets from Asset Reconstruction Company (India) Limited (ARCIL) and commenced production in 2005-06. Also in the same year, the company had launched intravenous fluids in the name of 'Nirlife' brand in the market. The Company had established the total purchase order commitments of Rs.216 crores for Pure Water Plant / Utilities Expansion and Caustic Plant in the year 2006-07. The Composite Scheme of Compromise and Arrangement with Core Healthcare Limited, its Lenders and shareholders (CHL) and the Company and its shareholders ('Scheme') were approved by the Hon'ble High Court of Gujarat vide its Order dated 1st March 2007. The Scheme became effective on 7th March of the year 2007. In November of the year 2007, Nirma purchased the American raw materials company Searles Valley Minerals Inc. Nirma closed its soda ash acquisition in January of the year 2008.

Nirma Ltd Chairman Speech

Nirma Ltd Company History

Nirma Limited (Nirma) was incorporated as a private limited company on 25th February 1980 to undertake the business of manufacturing and selling Synthetic Detergents, Soaps, Chemicals and Allied Products. It was promoted by Karsanbhai Patel as his pet project. The Company is engaged in the consumer goods and industrial products sector, having major manufacturing plants for production of various products includes Soda Ash, Linear Alkyl Benzene, Soaps, Detergents, Edible Salt, Industrial Salt and Others (Alfa Olefin Sulfonate, Sulfuric Acid, Glycerin and Single Super Phosphate). Also having separate unit for packaging. Nirma markets its products through its wholly owned subsidiary, Nirma Consumer Care Limited. The Company went to public in the year of 1993 as overcome from the status of deemed public limited. The Company came out with its maiden public issue of Equity Shares in the year 1994. During the same year, Nirma also ventured into manufacture of Fatty Acid, Glycerine, Toilet Soaps, Sulphuric Acid and Alfa Olefin Sulphonate (AOS). In 1995, the company had entered into an Agreement with Humphrey & Glasgow Consultants Ltd. for Detailed Engineering, construction supervision including Civil and Architectural Designs and Procurement Services for the Soda Ash Plant. During the year 1996, on account of modernisation, the company had successfully manufactured IP Grade (Pharmaceutical Grade) Glycerin. The associated companies including Nirma Detergents, Shiva Soaps and Detergents, Nirma Soaps and Detergents and Nilnita Chemicals were merged with the company during the period of 1996-1997. Nirma Consumer Care was formulated as a wholly-owned subsidiary of the company by the company in the year of 1997 itself. Nirma had completed successfully the state-of-the-art 80,000 TPA Linear Alkyl Benzene plant in the year 1998. During the year 1999, the edible salt market was set by the company to witness a keen battle with a new entrant, Nirma Salt, about to hit the market. In January of the year 2000, the 65,000 MTPA Normal Paraffin project was commissioned in a record 18 months time. Nirma had decided to acquire the business of Kisan Industries for the cash consideration of Rs 200 crore with effect from 1st April of the year 2000. During the year 2002, the company had undertaken the manufacturing process of toilet soap under the brand name 'Camay' for its subsidiary Nirma Consumer Care Ltd which obtains license from Procter & Gamble Home Products Ltd. In the same year of 2002, the company had closed its Bangladesh unit due to low sales volumes and entered into foods category with launch of Nirma Shudh Salt. Gujarat High Court approved the scheme of arrangement for demerger of operating division of Nirma Industries Ltd with the company in the year 2003. A tripartite agreement was made with Core Health Care Limited (CHL) and Assets Reconstruction Company (India) Limited in the matter of acquiring undertaking of CHL in the year of 2004. DURING 2004-05, the company had discontinued the production process at Pithampur in Madhya Pradesh and Jaipur in Uttar Pradesh. Nirma had obtained possession of some of the assets from Asset Reconstruction Company (India) Limited (ARCIL) and commenced production in 2005-06. Also in the same year, the company had launched intravenous fluids in the name of 'Nirlife' brand in the market. The Company had established the total purchase order commitments of Rs.216 crores for Pure Water Plant / Utilities Expansion and Caustic Plant in the year 2006-07. The Composite Scheme of Compromise and Arrangement with Core Healthcare Limited, its Lenders and shareholders (CHL) and the Company and its shareholders ('Scheme') were approved by the Hon'ble High Court of Gujarat vide its Order dated 1st March 2007. The Scheme became effective on 7th March of the year 2007. In November of the year 2007, Nirma purchased the American raw materials company Searles Valley Minerals Inc. Nirma closed its soda ash acquisition in January of the year 2008.

Nirma Ltd Directors Reports

<dhhead>Board’s Report</dhhead>

To,

The Members,

Your Directors have the pleasure of presenting the 43rd Annual Report together with Audited Financial Statements for the ?nancial year ended 31st March, 2023.

FINANCIAL RESULTS

The ?nancial performance of the Company is summarized below:

(? In crore)

Particulars

Consolidated

Standalone

2022-23

2021-22

2022-23

2021-22

Revenue from Operations

11,349

8,963

8,561

6,515

Other Income

140

158

125

148

Operating Pro?t (EBITDA)

2,139

1,697

2,151

1,584

Less:
(i) Finance Cost

211

319

163

279

(ii) Depreciation &Amortization Exp.

664

878

375

612

Pro?t Before Tax

1,264

500

1,613

693

Less: Total Tax Expenses

355

146

415

212

Pro?t for the year

909

354

1,198

480

 

DIVIDEND

With an objective to strengthen resources of the Company and for long term prospects, your Directors have decided not to recommend any dividend on shares for the year ended 31st March, 2023.

During the year under review, the Company has transferred a sum of ? 21.64 crore to the Debenture Redemption Reserve.

FINANCIAL PERFORMANCE

Consolidated ?nancial performance: On Consolidated basis, your Company has achieved revenue from operations of ? 11,349 crore for the ?nancial year ended 31 st March, 2023 as against ? 8,963 crore in previous year, registering 27% rise over the previous year. Consolidated Earnings before Finance Cost, Taxes, Depreciation and Amortisation (EBITDA) grew by 26 % to ? 2,139 crore in FY 2022-23 compared to

? 1,697 crore in FY 2021-22. After providing for taxation of ? 355 crore, your Company registered a Net Pro?t of ? 909 crore in FY 2022-23 compared to ? 354 crore in previous year, mainly on account of increase in revenue from operations, reduction in ?nance cost, depreciation and effect of changes in inventories.

The Net Worth of the Company on a consolidated basis stood at ? 9,193 crore as on 31st March, 2023.

Standalone ?nancial performance: Signi?cant increase in revenue, reduction in debt level, various cost initiatives taken by the Company lead to improvement in business performance and healthy operating pro?tability during the year under review. In terms of operating performance, Company’s revenue grew by 31% to ? 8,561 crore compared to ? 6,515 crore of previous year, mainly due to steep rise in realization of products such as soda ash. Standalone EBIDTA grew by 36% compared to previous year which stood at

? 2,151 crore during the year under review. Your company registered a Net Pro?t of ? 1,198 crore for FY 2022-23 compared to ? 480 crore of previous year.

BUSINESS OVERVIEW

Your Company has diversi?ed revenue pro?le and geographical presence with capacities in India and USA. For India operations also, revenue and pro?tability are well diversi?ed across soda ash, soaps and detergents, caustic soda, LAB and other industrial products. It has production facilities in Bhavnagar for soda ash, caustic soda, puri?ed phosphoric acid, bromine, salt and toilet soap, Porbandar for soda ash, Alindra for LAB and Mandali & Moraiya for detergent and soaps. It has soda ash operations in the USA at Searles Valley Minerals Inc, through its wholly-owned subsidiary, Karnavati Holdings Inc.

Soaps & Surfactants: Your Company continues to stand among the largest players in the domestic soaps and detergents segment having vast distribution network. Your Company is also one of the largest manufacturers of soda ash in the world, with capacities in India and the USA, besides having considerable market presence in caustic soda, detergents, toilet soaps and LAB. Backward integration is a major strategic strength. The Company manufactures key raw materials, including soda ash and linear alkyl benzene (LAB), which are used to make detergents. Captive production of raw materials ensures timely and adequate supply, and facilitates greater control over quality and raw material cost.

During the year under review, the demand for consumer products has remained healthy, along with recovery in demand and prices for industrial products such as soda ash and caustic soda. As the Company is catering largely to the price-sensitive economy segment, it faces high competition from unorganized players.

However your Company has established market position in the domestic soda ash and soaps and detergent businesses. The forward and backward integration coupled with considerable cost control on the cost structure, which continues to result in competitive advantage. The Company has also strengthened and established market position in Alkali Chemicals coupled with various cost initiatives that helped the Company in earning better pro?t margins. It has set up a larger capacity of soda ash than its captive requirements, strengthening its market position further in the soda ash business. The standalone revenue from Soda ash, LAB, caustic soda registered at ? 3,768 crore, ? 867 crore and ? 1,047 crore respectively during the year under review.

Salt: Your Company is the second largest player in the edible salt business in the country with large and automated salt pans in Gujarat, which provide a steady supply of salt for soda ash production. The revenue from Salt registered at ? 384 crore during the year backed by strong demand for the product.

Other Chemicals: Your Company’s operations are further backward integrated to manufacture n-para?ns and other chemicals too. It also manufactures various other chemicals and fertilizer products like single super phosphate, bromine etc. and has set up a food grade puri?ed phosphoric acid plant. These products helped to strengthen the operations of the Company.

Processed Minerals: This business segment constitutes the Company’s operations in USA through its subsidiary, which manufactures a range of processed minerals such as Boron, Natural Soda Ash and others.

Utilities: Power and Fuel are one of the key inputs for the various products manufactured by the Company. The Company has the ?exibility to utilize a variety of fuels from 3400 GCV to 8500 GCV and is optimizing the fuel mix strategy to its full advantage. Your Company has power generation facilities with present installed capacity of more than 237 MW.

FINANCE

Your Company continues to focus on effective planning towards the timely availability of ?nance at competitive rates. The Company has funded its requirements through a mix of internal cash accruals, short term and long term borrowings. Further healthy cash accruals over the past three years resulted into high liquidity which shall not only cover the debt obligations comfortably but also to cater the other needs of the Company. To maintain healthy leverage position, your Company undertook signi?cant deleverage exercise in past two years.

During the year under review, your Company has :

    • Redeemed 9000, 9.50% Unsecured, Subordinated, Rated, Listed, Redeemable Non-Convertible Debentures (NCDs Series IV – Tranche 1) aggregating to ? 900 crore, on 6th July, 2022 by exercising call option.
    • Raised funds by issue of 1000 Unsecured, Rated, Listed, Redeemable, Non-Convertible Debentures (NCDs Series VI) on private placement basis, aggregating to ? 100 crore for capital expenditure/ re?nance of existing borrowing.
    • Raised short term funds by issuing Commercial Papers as and when required.

During the year under review, CRISIL Limited has rea?rmed its ratings and revised outlook from Negative to Stable. The revised ratings for NCDs series V and Long Term Bank Facilities are CRISIL AA/Stable. The revised rating for NCDs series IV Tranche 1, redeemed during the year was CRISIL AA-/Stable.

As at 31st March, 2023, the credit ratings assigned to the Company for its borrowings including debt securities are:

    • secured listed NCDs Series V: CRISIL AA/Stable
    • unsecured listed NCDs Series VI: CRISIL AA/Stable
    • long term banking facilities : CRISIL AA/Stable and ICRA AA/Positive
    • short term rating : CRISIL A1+ and ICRA A1+

MATERIAL CHANGES

There are no material changes and commitments affecting the ?nancial position of the Company which have occurred between the end of the ?nancial year 2022-23 and the date of this report.

SUBSIDIARIES, ASSOCIATE COMPANIES AND JOINT VENTURE

The Company has one Wholly Owned Subsidiary and four step down wholly owned subsidiaries as on 31st March, 2023.

Karnavati Holdings Inc. ("KHI"), USA (WOS of the Company), Searles Valley Minerals Inc. ("SVM"), USA (WOS of KHI) and Searles Domestic Water Company LLC, Trona Railway Company LLC & Searles Valley Minerals Europe (WOS of SVM), continued to be step down subsidiaries of the Company.

The highlights of performance of subsidiaries of the Company in the form of contribution of each of the subsidiaries and associates in terms of the revenue and pro?t is provided in Form AOC-1, which forms part of the Annual Report in terms of Section 129(3) of the Companies Act, 2013 ("the Act"). Further, pursuant to the provisions of Section 136 of the Act, the ?nancial statements of the Company, consolidated ?nancial statements along with other documents required to be attached thereto and audited accounts in respect of subsidiaries, are available on the website of the Company.

SHARE CAPITAL

As at 31st March, 2023, the paid up Equity Share Capital of the Company is ? 73.04 crore comprising of 14,60,75,130 Equity Shares of ? 5/- each. During the year under review, the Company has not issued shares or convertible securities or shares with differential voting rights nor has granted any stock options or sweat equity or warrants.

DIRECTORS AND KEY MANAGERIAL PERSONNEL

The Board at its meeting held on 30th May, 2022 appointed Shri Pankaj R. Patel as an Additional Director (Non-executive & Non independent) of the Company. The members of the Company at Annual General Meeting held on 26th September, 2022 approved his appointment in pursuance to the provisions of Section 161 of the Act.

Shri Vijay R. Shah and Smt. Purviben A. Pokhariyal ceased as an Independent Directors of the Company with effect from 5th March, 2023 on completion their two consecutive terms as an Independent Director.

On recommendation of Nomination and Remuneration Committee, the Board has appointed Shri Kaushikbhai

N. Patel (DIN 00145086), Non-executive Director of the Company as an Independent Director, for the period of ?ve years effective from 31st March, 2023, subject to approval of members of the Company for appointment as an Independent Director.

The Board has on 31st March, 2023 resolved to appoint Smt. Tejalben Amitkumar Mehta, as an Additional Director (Non-executive & Independent) subject to obtaining Director Identi?cation Number ("DIN"). The Board has thereafter formally appointed her on 18th May, 2023 for the period of ?ve years, upon obtaining DIN (DIN 10125072), subject to approval of members of the Company.

In the opinion of the Board, the Independent Directors appointed during the year possess requisite expertise, integrity and experience (including pro?ciency) for such appointment.

As per the provisions of Section 152 of the Act, Shri Shailesh V. Sonara (DIN 06592025), Director of the Company is liable to retire by rotation at the forthcoming Annual General Meeting and being eligible, offer himself for re-appointment. The Board recommends his re-appointment.

The Company has received declarations from all the Independent Directors that they meet the criteria of independence as laid down under Section 149(6) of the Act. Based on the declarations, the Board con?rms that the Independent Directors ful?ll the conditions of independence speci?ed in Section 149(6) of the Act. The Independent Directors have registered themselves with the Independent Director’s Database maintained by the Indian Institute of Corporate Affairs in terms of Section 150 of the Act read with Rule 6 of the Companies (Appointment & Quali?cation of Directors) Rules, 2014.

None of the Directors of the Company are disquali?ed for being appointed as Directors as speci?ed under Section 164(2) of the Act read with Rule 14(1) of the Companies (Appointment and Quali?cation of Directors) Rules, 2014.

There has been no change in Key Managerial Personnel during the year under review. In terms of the provisions of Section 2(51) and Section 203 of the Act, Shri Hiren K. Patel, Managing Director, Shri Shailesh

V. Sonara, Whole time Director, Shri Manan Shah, Chief Financial O?cer and Shri Paresh Sheth, Company Secretary of the Company are the Key Managerial personnel of the Company.

DIRECTORS’ RESPONSIBILITY STATEMENT

Pursuant to Section 134(3c) read with Section 134(5) of the Act, your Directors state that:

    1. in the preparation of the annual accounts, the applicable accounting standards have been followed along with proper explanation relating to material departures for the year ended 31st March, 2023;
    2. the directors have selected such accounting policies and applied them consistently and made judgments and estimates that are reasonable and prudent so as to give a true and fair view of the state of affairs of the company at the end of the ?nancial year and of the pro?t of the company for that period;
    3. the directors have taken proper and su?cient care for the maintenance of adequate accounting records in accordance with the provisions of this Act for safeguarding the assets of the company and for preventing and detecting fraud and other irregularities;
    4. the directors have prepared the annual accounts on a going concern basis;
    5. the directors have devised proper systems to ensure compliance with the provisions of all applicable laws and that such systems were adequate and operating effectively.

NUMBER OF MEETINGS OF THE BOARD

During the year under review ?ve meetings of Board of Directors were held on 16th April, 2022, 30th May, 2022, 10th August, 2022, 8th November, 2022 and 4th February, 2023. The gap between two meetings did not exceed one hundred and twenty days.

COMMITTEES

The Board of Directors has following committees constituted in accordance with the applicable provisions of the Act with speci?c terms of reference and activities. The minutes of the Committee Meetings were placed before the Board for review and noting.

    1. Audit Committee
    2. Nomination and Remuneration Committee
    3. Corporate Social Responsibility Committee
    4. Investment Committee

Audit Committee:

The Company’s Audit Committee was comprised of Shri Vijay R. Shah, Chairman, Shri Shailesh V. Sonara and Smt. Purviben A. Pokhariyal, Members. The terms of Shri Vijay R. Shah and Smt. Purviben A. Pokhariyal as Independent Directors of the Company were completed on 4th March, 2023 and accordingly ceased as members. Shri Kaushikbhai N. Patel, Independent Director has been appointed as Chairman of the Audit Committee and Smt. Tejalben A. Mehta, Independent Director has been appointed as a member of the Audit Committee, both effective from 18th May, 2023.

The terms of reference of the Audit Committee covers the areas mentioned in Section 177 of the Act, inter- alia includes the following:

    • examination of the ?nancial statements and auditors report thereon;
    • review and monitor auditors independence and performance, and effectiveness of audit process;
    • recommendation for appointment, remuneration of auditors;
    • scrutiny of inter-corporate loans and investments;
    • review compliance with the provisions of SEBI (Prohibition of Insider Trading) Regulations;
    • approval or any subsequent modi?cation of transactions with related parties;
    • evaluation of internal ?nancial controls and risk management system.

During the year under review, six meetings of the Audit Committee were held on 16 th April, 2022, 30th May, 2022, 10th August, 2022, 7th November, 2022, 3rd February, 2023 and 2nd March, 2023. The intervening gap between two meetings did not exceed one hundred and twenty days. All the recommendations made by the Audit Committee during the year under review were accepted by the Board. The Chairman of the Audit Committee attended the last Annual General Meeting held on 26th September, 2022.

There was no instance of fraud which required the Statutory Auditors to report to the Audit Committee and / or Board under Section 143(12) of the Act and Rules framed thereunder during the year.

Nomination and Remuneration Committee:

The Company’s Nomination and Remuneration Committee ("NRC") was comprised of Shri Kaushikbhai N. Patel, Chairman, Shri Vijay R. Shah and Smt. Purviben A. Pokhariyal, Members. The terms of Shri Vijay R. Shah and Smt. Purviben A. Pokhariyal as Independent Directors of the Company were completed on 4th March, 2023 and accordingly ceased as members. Shri Rakesh K. Patel, Vice Chairman (Non-executive Director) and Smt. Tejalben A. Mehta, Independent Director have been appointed as a member of the NRC, both effective from 18th May, 2023.

The terms of reference of the NRC covers the areas mentioned in Section 178 of the Act, inter-alia includes:

    • to formulate criteria for determining quali?cations, positive attributes and independence of a Director;
    • to identify persons who are quali?ed to become Directors and who may be appointed in Senior Management and to recommend to the Board their appointment /removal.
    • to specify the manner for effective evaluation of performance of Board, its committees and individual directors.

The salient features of the Nomination and Remuneration Policy and changes therein:

The Company’s Nomination and Remuneration Policy had been formulated and maintained inter alia to meet the objectives:

    • to ensure that level and composition of remuneration is reasonable and su?cient to attract and motivate Directors, Key Managerial Personnel;
    • to ensure balance between ?xed and incentive pay for remuneration to Directors, key managerial personnel and senior management, re?ecting short and long-term performance objectives appropriate to the working of the company and its goals.

The salient features of the policy inter alia include:

    • the role of the Committee to formulate criteria for determining quali?cations, positive attributes and independence of director, to identify persons quali?ed to become directors, senior management & recommend their appointment and removal to the Board and also to recommend policy relating to remuneration of Directors, Key Managerial Personnel and Other Employees;
    • Term and Tenure for Managing Director, Whole Time Directors and Independent Directors;
    • Policy for remuneration to Director, Key Managerial Personnel and Senior Management.

During the year under review, two meetings of NRC were held on 30th May, 2022 and 2nd March, 2023. The Nomination and Remuneration Policy of the Company is available on the website of the Company viz. www.nirma.co.in.

Corporate Social Responsibility Committee

The Company’s Corporate Social Responsibility Committee ("CSR") was comprised of Shri K. K. Patel, as Chairman, Smt. Purviben A. Pokhariya, Independent Director as member and Shri Hiren K. Patel, Managing Director as member. The terms of Smt. Purviben A. Pokhariyal as Independent Director of the Company were completed on 4th March, 2023 and accordingly ceased as member. Shri Kaushikbhai N. Patel, Independent Director has been appointed as a member of the CSR Committee, effective from 18th May, 2023.

During the year under review, two meetings of CSR Committee were held on 16th April, 2022 and 30th May, 2022.

Investment Committee

The Board has constituted "Investment Committee of Directors" comprises of Shri Rakesh K. Patel, Shri Hiren

K. Patel, Shri Shailesh V. Sonara and Shri Kaushikbhai N. Patel entrusted with clearly de?ned roles and powers with speci?ed limits mainly relating to borrow / invest funds, to grant / avail loan, to provide security etc.

Three meetings of the Investment Committee were held on 28th June, 2022, 5th July, 2022 and 27th February, 2023 during the year under review.

PERFORMANCE EVALUATION

Pursuant to provisions of the Act and Rules made thereunder, the NRC has carried out annual evaluation of the performance of the Board, its Committees and of individual directors ("Evaluation").

The Evaluation was carried out considering the various aspects such as functioning of the Board and Committees such as structure, independence of judgment, effective participation, performance, availability and ful?llment of functions assigned to them.

The Independent Directors of the Company met on 2nd March, 2023, without the attendance of Non- Independent Directors and members of the management to review the performance of the Chairman and Managing Director of the Company and to assess the quality, quantity and timeliness of ?ow of information between the management and the board of directors.

CONSERVATION OF ENERGY, TECHNOLOGY ABSORPTION, FOREIGN EXCHANGE EARNINGS AND OUTGO

The information on conservation of energy, technology absorption and foreign exchange earnings and outgo stipulated under Section 134(3)(m) of the Act, read with Rule 8 (3) of The Companies (Accounts) Rules, 2014 is annexed to this Report as Annexure - I and forms part of this Report.

AUDITOR & AUDITORS’ REPORT

M/s. Rajendra D. Shah & Co., Chartered Accountants (Firm Registration No. 108363W) were appointed as Auditors of the Company to hold o?ce for ?ve years from the conclusion of 37th Annual General Meeting ("AGM") held with respect to the ?nancial year 2017-18 till the conclusion of the 42nd AGM, which was held on 26th September, 2022.

The Board of Directors of the Company at their meeting held on 10th August, 2022 on the recommendation of the Audit Committee and the members of the Company at 42nd AGM have approved the appointment of M/s. Hemanshu Shah & Co., Chartered Accountants, (Firm registration no. 122439W), Ahmedabad, as the Auditors of the Company in place of M/s. Rajendra D. Shah & Co., the retiring Auditors, to hold O?ce for a period of ?ve years from the conclusion of 42nd AGM till the conclusion of the 47th AGM.

The Notes to the ?nancial statements referred in the Auditors’ Report are self-explanatory. There are no quali?cations or reservations or adverse remarks or disclaimers given by Statutory Auditors of the Company and therefore do not call for any comments under Section 134 of the Act. The Auditors’ Report is enclosed with the ?nancial statements in this Annual Report.

SECRETARIAL AUDITOR & AUDIT REPORT

In pursuance to the provisions of section 204 of the Act read with Companies (Appointment and Remuneration of Managerial Personnel) Rules, 2014, M/s Kashyap R. Mehta & Associates, Practicing Company Secretaries (Firm Registration No. S2011GJ166500) was appointed by the Board to undertake the Secretarial Audit of the Company for the ?nancial year 2022-23. The Secretarial Audit Report is annexed as Annexure II and forms an integral part of this report. There are no quali?cations, reservations or adverse remarks given by the Secretarial Auditor in their report.

COST AUDITOR

In pursuance to provisions of section 148 of the Act read with the Companies (Cost Records and Audit) Rules, 2014 as amended from time to time, the cost audit records maintained by the Company are required to be audited by the Cost Auditor.

The resolution pertaining to remuneration payable to the Cost Auditors as may be approved by the Board, shall forms part of the notice convening the Annual General Meeting for rati?cation by members as required under the Act and rules made thereunder.

EXTRACT OF ANNUAL RETURN

Pursuant to Section 92(3) of the Act read with the applicable Rules framed thereunder, the Annual Return for the year ended 31st March 2023 can be accessed on the Company’s website www.nirma.co.in.

PARTICULARS OF EMPLOYEES

As per the provisions of the Act, your Company is not listed Company, since only debt securities of the Company are listed. The disclosure as required under section 197 (12) of the Act, read with Rules 5 of the Companies (Appointment and Remuneration of Managerial Personnel) Rules, 2014 pertaining to particulars of employees and remuneration are not applicable to the Company for the year under review.

SECRETARIAL STANDARD

During the year 2022-23, the Company has complied with the all applicable Secretarial Standards issued by the Institute of Company Secretaries of India.

VIGIL MECHANISM

The Company has in place Vigil Mechanism cum Whistle Blower Policy in compliance with the provisions of the Act and Regulations under SEBI LODR and SEBI (Prohibition of Insider Trading) Regulations, 2015, for the directors and employees to report their genuine concern or grievances, to freely communicate concerns about illegal or unethical practices and to report instances of leak of unpublished price sensitive information. Vigil Mechanism cum Whistle Blower Policy is available on the Company’s website. The mechanism provides for adequate safeguards against victimization of employees and Directors who use such mechanism and makes provision for direct access to the management or to the Chairman of Audit Committee in exceptional cases.

No complaint was reported under said mechanism during the year 2022-23.

In compliance with the Sexual Harassment of Women at Workplace (Prevention, Prohibition and Redressal) Act, 2013, Internal Complaints Committees have been set up by the Company to redress any complaints received related to sexual harassment of women at the workplace. No complaint was reported during the year 2022-23.

PARTICULARS OF LOANS, GUARANTEES OR INVESTMENTS BY THE COMPANY

In pursuance to the provisions of section 186 of the Act, particulars of Loans given, Investments made and Guarantees given or security provided, are given in the notes to Financial Statements.

RELATED PARTY TRANSANCTIONS

All related party transactions entered into during the ?nancial year were on an arm’s length basis. No material related party transactions as prescribed in Section 188(1) of the Act read with Rule 15(3) of the Companies (Meetings of Board and its Powers) Rules, 2014 were entered in to during the year, and hence disclosure in Form AOC-2 is not applicable. The Audit Committee has granted its prior Omnibus approval on a yearly basis for the related party transactions which are foreseeable and repetitive in nature, within the limits authorized by the Board. Other Related Party Transactions were placed before the Audit Committee for review & approval and also before the Board for approval, wherever required.

The Audit Committee and the Board on a quarterly basis has reviewed and noted the statement giving details of all related party transactions during the year 2022-23. The related party transactions as are required under Indian Accounting Standard-24 are set out in the notes to the ?nancial statements.

RISK MANAGEMENT & INTERNAL CONTROL

The Company has in place a Risk Management Framework promoting a proactive approach in identifying, evaluating, reporting and resolving risks associated with the business. The framework is instrumental for prioritization of risks to be monitored to cover all the functions and internal risk factors, as a systematic approach to control the risk. The functional head identi?es the probable risks in their area of operation, which are assessed, analyzed for its root cause and criticality of their impact and after deliberation mitigation steps with action plan and responsibility are rolled out.

Your Company has put in place robust internal control systems commensurate with its size and scale of operations. Internal control system provides reasonable assurance on the effectiveness of its ?nancial and operational information, reliability of ?nancial reporting, compliance with applicable accounting standards. The Company has in place a well-designed data protection system.

The Company has Internal Audit Department, which on regular intervals test all key controls to ensure that the controls are operating effectively. During the course of internal audit, control matrix of respective processes is referred and process walkthrough along with sample testing is done to validate to the controls.

On quarterly basis the head of internal audit department submits internal audit updates and presents audit observation to the Audit Committee. The Audit Committee reviews the ?ndings of internal audit and necessary actions are being taken. The Company has adequately insured its assets against various risks.

 

CORPORATE SOCIAL RESPONSIBILITY

The CSR activities during the year were under the thrust areas of promoting education, Girls’ hostel, Rural development, making available safe drinking water, sanitation, healthcare, animal welfare, ensuring environment sustainability etc. The annual report on CSR activities for the ?nancial year ended 31st March, 2023 is set out in Annexure- III and forms an integral part of this report. The CSR Policy of the Company is available on the website of the Company at www.nirma.co.in.

CONSOLIDATED FINANCIAL STATEMEN T

The Consolidated Financial Statements has been prepared in accordance with applicable Indian Accounting Standards and forms an integral part of this Report.

In pursuance to Section 129(3) of the Act, read with rules framed thereunder and relevant Indian Accounting Standards as applicable, the Company has prepared its Consolidated Financial Statements with its subsidiaries which form part of this Annual Report.

DEPOSITS

During the year under review, your Company has not accepted any Deposit in pursuance to the provisions of Section 73 / 76 of the Act. No amount was outstanding towards unclaimed deposit as on 31st March, 2023.

However, the Company has received a loan of ? 19.50 crore from relative of Promoter who are Directors, from time to time during the year @ 8% interest p.a. to meet the timely business requirements of the Company. They have furnished a declaration in writing to the effect that the amount was not been given out of funds acquired by them by borrowing or accepting loan or deposits from others.

GENERAL DISCLOSURES

Your Directors states that during the year under review:

    1. the disclosures have been made in this report for the items as prescribed in section 134(3) of the Act and rule 8 of the Companies (Accounts) Rules, 2014 to the extent applicable and transactions took place on those items during the year under review;
    2. no application has been made or any proceeding pending against the Company under the Insolvency and Bankruptcy Code, 2016 (31 of 2016);
    3. no signi?cant and material orders passed by the regulators or courts or tribunals impacting the going concern status of the Company and its operations in future;
    4. no instances where the Company required the valuation for one-time settlement or while taking the loan from the Banks or Financial institutions.

ACKNOWLEDGEMENT

The Directors take this opportunity to express gratitude for the support and co-operation extended by Government and statutory authorities and look forward to their continued support in the future. The Directors pleased to place on record their sincere appreciation for the support given by the customers, vendors, shareholders, lenders. The Directors wish to place on record their appreciation for employees at all levels for their dedicated efforts and consistent contribution during the year.

 

 

Nirma Ltd Company Background

No Data Found

Nirma Ltd Company Management

Director NameDirector DesignationYear
KARSANBHAI KHODIDAS PATELChairman & Non Executive Dir.2023
RAKESH KARSANBHAI PATELVice Chairman (Non-executive)2023
Pankaj R PatelIndependent Non Exe. Director2023
KAUSHIKBHAI NANDUBHAI PATELIndependent Non Exe. Director2023
Vijay R ShahIndependent Non Exe. Director2023
PURVI ANANTANAND POKHARIYALIndependent Non Exe. Director2023
SHAILESHBHAI VALJIBHAI SONARAExecutive Director2023
HIREN KARSANBHAI PATELExecutive Director & MD2023
Tejalben A. MehtaIndependent Non Exe. Director2023

Nirma Ltd Listing Information

Nirma Ltd Finished Product

Product NameUnit Installed
Capacity
Production
Quantity
Sales
Quantity
Sales
Value
Soda AshMT0002232.47
DetergentsMT0001062.05
Caustic SodaMT000640.67
OthersNA000604.67
Cement & ClinkerNA000591.54
Toilet SoapsMT000548.11
Linear AlkylbenzeneMT000471.15
Other Operating RevenuesNA00044.16
Others - TradedNA00025.34
Soda Ash-TradedNA00015.48
Processing ChargesNA0001.9
Cement - TradingNA0000.03
Sulphuric AcidMT0000
DisposablesNol0000
Excise dutyNA0000
OthersNol0000
Refined BicarbonateNA0000
Sale of Traded GoodsNA0000
SalesNA0000
Packing materialsMT0000
Castor OilNA0000
Distilled Fatty AcidMT0000
GlycerineMT0000
SaltMT0000
BoraxNA0000
Alfa Olefin SulphonateMT0000
Pharma ProductsNA0000
CapsulesNol0000
Dry SyrupsNol0000
InfusionsNol0000
InjectablesNol0000
Injectables(Bags)Nol0000
Injectables(Dry Powder)Nol0000
Injectables(Glass)Nol0000
Liquid OralsNol0000
Ointment & CreamsNol0000
TabletsNol0000
Single Super PhosphateMT0000
ShampoosMT0000
ToothpasteMT0000

Contact us Contact us